Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction. The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The secondary goals are to assess the survival rate, clinical and functional outcomes, the quality of life, and the rate of complications at 1 month, 1 year and 2 years post-operatively.


Clinical Trial Description

This s a prospective, multicenter, non-controlled, observational study to evaluate the outcomes of Medacta Anatomic Ribbon Surgery (M-ARS) in the reconstruction of the anterior cruciate ligament (ACL). Participants will be informed about the study, both orally and in writing, during a preoperative visit. The investigator will answer any questions that may arise and will collect the informed consent. During the study, enrolled participants will be able to withdraw at any time and for any reason. The study is conducted according to the following schedule: - V1 : Inclusion during a preoperative visit - V2: Surgery - V3: Follow-up visit at 1 month ± 15 days post-surgery - V4: Follow-up visit at 6 months ± 30 days post-surgery - V5: Follow-up visit at 12 months ± 60 days post-surgery - V6: Follow-up visit at 24 months ± 90 days post-surgery The following data will be collected: - Survival rate of implants evaluating the incidence of implants failure, where implant failure is defined as revision, loosening, or any definite change in the position of components (V3-V6). - Clinical and functional outcomes, measured with the International Knee Documentation Committee (IKDC) score (V1, V3-V6) - Quality of Life, measured with the EQ-5D score (V1, V3-V6) - Occurrence of intraoperative and postoperative complications (V2-V6) Depending on standard practice, imaging assessment of implants and bone tunnels may be performed. A web-based data collection tool will be used as Electronic Data Capture (EDC). All the information required by the protocol will be collected in electronic case report forms (eCRF). The statistical analysis will be performed according to a pre-established statistical analysis plan. Missing values will not be replaced by estimated values but will be considered as missing in the statistical analysis. ;


Study Design


Related Conditions & MeSH terms

  • Anterior Cruciate Ligament (ACL) Reconstruction

NCT number NCT04462458
Study type Observational
Source Medacta International SA
Contact Denise Falcone
Phone +41916966060
Email falcone@medacta.ch
Status Recruiting
Phase
Start date July 1, 2022
Completion date January 2027

See also
  Status Clinical Trial Phase
Completed NCT03417479 - Gabapentin Premedication for ACL Reconstruction: RCT
Withdrawn NCT03562299 - OrthoPureā„¢ XT Pilot Clinical Study N/A
Completed NCT03211728 - Does Perioperative Pregabalin Reduce Postoperative Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery Under Spinal Anesthesia? N/A
Recruiting NCT06382324 - The Psychological Impact of Mindfulness Intervention to Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06347523 - VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction N/A